Q: Are there any stocks in TELEMEDICINE TECH Companies ETF in Canada or the USA. Can you please give us few stocks examples that you like.
Thanks for the great service
Hector
Thanks for the great service
Hector
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hi
Any news on why Resmed was down 13% after a positive 2nd quarter result?
Thank you.
Any news on why Resmed was down 13% after a positive 2nd quarter result?
Thank you.
Q: Thoughts on the quarter? Do you recommend?
Q: Hi,
What do you think selling Pfizer on a profit and replace it with XLV. The reason Im doing this, is just comparing them and think XLV has more capital appreciation. Do you know what's the growth outlook on Pfizer?
Appreciate your thoughts.
Thanks,
Sunday
What do you think selling Pfizer on a profit and replace it with XLV. The reason Im doing this, is just comparing them and think XLV has more capital appreciation. Do you know what's the growth outlook on Pfizer?
Appreciate your thoughts.
Thanks,
Sunday
Q: What are the - and - for Thermo Fisher?
Why does ISRG screen better for you?
Thanks for all your insightful work.
Mark
Why does ISRG screen better for you?
Thanks for all your insightful work.
Mark
Q: Comments on VMD’s quarterly results?
Q: what does knight therapeutics as an investment today offer an investor with a long term outlook and patience
Q: What do you think of WELL’S announcement today? Almost feels like the company is losing focus. Transforming into a cyber security company? How could they possibly compete with the larger names such as Blackberry & Absolute? Market seems to like it though.
Q: Hi 5i,
Invitae just reported results and the stock was down 10% after hours. Can you give your thoughts on the quarter and its prospects going forward? I've held it for awhile and plan on continuing to hold for 3+ years.
Thanks!
Invitae just reported results and the stock was down 10% after hours. Can you give your thoughts on the quarter and its prospects going forward? I've held it for awhile and plan on continuing to hold for 3+ years.
Thanks!
Q: Is there a potentially worthwhile option in the Canadian market for a company that's working on a vaccine, even indirectly?
Q: Could you comment on Gild earnings and your feelings on the company going forward. It is down today; would you consider it a buy, hold or sell? Thank you!
Q: Peter, Ryan and staff; RPRX has been suggested as a reasonable entery into the US Pharmaceutical industry. I personally know little of the industry so your opinion would be greatly appreciated.
Your past advice and suggestions have made retirement quite enjoyable. Thank you in advance for your help.
Your past advice and suggestions have made retirement quite enjoyable. Thank you in advance for your help.
Q: LMNL went up 100 % - Why ? De-listing from TSX ? Appreciate your comments. Thank you
Q: Hello,
Thank you for your very prompt response to my question concerning how this ETF is able to pay such a high distribution. I now however have a few follow-on questions.
Since you indicated that a vast percentage of the distribution the ETF paid in the past year was simply a return of investors capital, wouldn't that make the likelihood of the ETF being able to continue payment of the current high yield very suspect over a rather short period of time? If investors are predominantly receiving a return of their own capital back to them, over time, then at a rate of 9% plus per year, won't the fund simply run out of funds to make these payments with over a period of 10 or so years? How would this differ from putting one's money under the mattress and simply withdrawing 10% of it each year?
Does the Evolve Global Healthcare (LIFE) ETF also engage in this practice, in order to support its roughly 6.75% yield?
If ETFs are supporting high yields by returning investor's capital to them and if that practice is inherently unsustainable, then I imagine that including information of that nature in the answer to any and all inquiries about such ETFs, would be very beneficial to all your members.
Thank you
Thank you for your very prompt response to my question concerning how this ETF is able to pay such a high distribution. I now however have a few follow-on questions.
Since you indicated that a vast percentage of the distribution the ETF paid in the past year was simply a return of investors capital, wouldn't that make the likelihood of the ETF being able to continue payment of the current high yield very suspect over a rather short period of time? If investors are predominantly receiving a return of their own capital back to them, over time, then at a rate of 9% plus per year, won't the fund simply run out of funds to make these payments with over a period of 10 or so years? How would this differ from putting one's money under the mattress and simply withdrawing 10% of it each year?
Does the Evolve Global Healthcare (LIFE) ETF also engage in this practice, in order to support its roughly 6.75% yield?
If ETFs are supporting high yields by returning investor's capital to them and if that practice is inherently unsustainable, then I imagine that including information of that nature in the answer to any and all inquiries about such ETFs, would be very beneficial to all your members.
Thank you
Q: A co-worker of mine has brought up this company to my attention last couple of days it looks like this company went public just this past FEBRUARY, i know that it is very new to the stock market do you have any inside information on this company. Thank you
again Wilson
again Wilson
Q: I see this company has just listed on the TSX. What are your thoughts on its financials and potential for growth. Are the management team considered strong in your view. Thanks.
Q: So at what point to you throw in the towel? You have done that to numerous stocks and said the money could be put to better use. This stock has been a waste of money, why would anybody want a health care stock that has this record. Do you really think that one day this company is going to make a deal that is going to make it explode and make up for the waste of time that you have been promoting it.
Sorry but i had to get this off my back.
Sorry but i had to get this off my back.
Q: This is an observation on Knight after your response to Cheryl's inquiry and your revised position stating you are getting edgy about this company.
One aspect of investing I have learned from my time with 5i is to have patience with a company and to not react to one quarter results.
Regarding Knight, we waited and waited and finally they did a solid acquisition which closed at the end of November 2019. 5i indicated it was a good deal for Knight.
They have not completed the deal as they are still pursuing the 48% from BTO shareholders. This is an unusual way to buy a company and it taking a long time.
However, after they pay everything, they will have no debt, lots and lots of cash and have repurchased over 12M Knight shares. They are presently doing a second NCIB with the intent of buying another 10,8M shares. So, they are buying 20% of the floating shares, enhancing shareholder value. Should they have started a dividend instead? I think that was too early and approve of their share repurchase. However, does that mean they don't see any future deals on the near term horizon? I do not know but they will still have a few hundred million...
They have now reported one quarter. The sales met one analyst's estimate but fell short with the other two. Not exactly a disaster considering it is a new company in new and faraway countries during a pandemic. The company says the virus is a non-factor but many in South America, and everywhere, are more reluctant than usual to seek medical treatment that is not absolutely necessary because we want to stay home and that has to hurt drug sales.
I think this company's share price will be double by this time next year and will be approaching $25 - $30 by the end of 2023. Considering the high valuations in the market today, this seems like a prudent investment. If they have not performed by December 2023, I will sell my large position and take the bath. However, I am not buying any soap today.
Do you have any update on whether they have purchased any shares on the second repurchase? And, they were late reporting the last quarter so when do they report again?
It is almost unthinkable to differ from your opinion on any stock because you are all so smart. We'll just have to see on this one but I think it's too early to expect so much after waiting so long...
Thank you.
One aspect of investing I have learned from my time with 5i is to have patience with a company and to not react to one quarter results.
Regarding Knight, we waited and waited and finally they did a solid acquisition which closed at the end of November 2019. 5i indicated it was a good deal for Knight.
They have not completed the deal as they are still pursuing the 48% from BTO shareholders. This is an unusual way to buy a company and it taking a long time.
However, after they pay everything, they will have no debt, lots and lots of cash and have repurchased over 12M Knight shares. They are presently doing a second NCIB with the intent of buying another 10,8M shares. So, they are buying 20% of the floating shares, enhancing shareholder value. Should they have started a dividend instead? I think that was too early and approve of their share repurchase. However, does that mean they don't see any future deals on the near term horizon? I do not know but they will still have a few hundred million...
They have now reported one quarter. The sales met one analyst's estimate but fell short with the other two. Not exactly a disaster considering it is a new company in new and faraway countries during a pandemic. The company says the virus is a non-factor but many in South America, and everywhere, are more reluctant than usual to seek medical treatment that is not absolutely necessary because we want to stay home and that has to hurt drug sales.
I think this company's share price will be double by this time next year and will be approaching $25 - $30 by the end of 2023. Considering the high valuations in the market today, this seems like a prudent investment. If they have not performed by December 2023, I will sell my large position and take the bath. However, I am not buying any soap today.
Do you have any update on whether they have purchased any shares on the second repurchase? And, they were late reporting the last quarter so when do they report again?
It is almost unthinkable to differ from your opinion on any stock because you are all so smart. We'll just have to see on this one but I think it's too early to expect so much after waiting so long...
Thank you.
Q: Hi
Could you please compare Abbott and Dexcom. I am hopeful that the Diabetic Glucose Monitors market will be profitable. I think I am not alone with this giving the valuation of DXCM...,or would ABT win the comparison on size, diversity, etc.? Thank you for helping us out with your insight.
Could you please compare Abbott and Dexcom. I am hopeful that the Diabetic Glucose Monitors market will be profitable. I think I am not alone with this giving the valuation of DXCM...,or would ABT win the comparison on size, diversity, etc.? Thank you for helping us out with your insight.
Q: What is going on with GUD in your opinion? The market is not liking it too much.